Abstract
Effectiveness and Tolerability of Dual Therapy with Dolutegravir Plus Darunavir/c in Treatment-Experienced Patients with HIV: A 144-Week Follow-Up
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
